BBC BLOGS - Fergus's Medical Files

Archives for March 2011

Spreading good practice in the health service

Fergus Walsh | 08:59 UK time, Wednesday, 30 March 2011


The blood flow monitor could save the NHS huge sums of money

The blood flow monitor could save the NHS huge sums of money

How can the NHS speed up the way it spreads good practice? That is a key issue which emerges out of new guidance from the health watchdog NICE to hospitals throughout England.

It has strongly supported the use of a blood flow monitor during major surgery which reduces complications and speeds the recovery of patients. You can read more about the story here and the full guidance from NICE.

This is not the first time that the monitor has been shown to be effective.

Over the past decade there has been a steady flow of clinical trials and assessments which have demonstrated that it benefits patients and budgets. In a cash-strapped health service it is worrying that the NHS is taking so long to adopt good ideas.

Professor Monty Mythen, from University College Hospital London, which has been using the monitor for 15 years, said it was partly down to what he called "silo-budgeting".

He said: "The cost of the probe - about £100 a time - comes out of the anaesthetics budget. That is a big extra cost. It saves £1,000 in the weeks to come but that saving goes to the surgical budget." This suggests a worrying lack of joined-up thinking.

NICE suggests that more than 800,000 patients a year in England could benefit from being monitored using the ultrasound device. Those are patients undergoing major or high-risk surgery. At present fewer than 25,000 patients are monitored using it.

Of course patients have no idea whether they have had their blood flow monitored using the ultrasound machine, because it is introduced into their oesophagus when they are under a general anaesthetic.

But surgical teams and hospital managers have a duty to ensure that proven technologies which benefit patients get used - especially when they also save the NHS a huge amount of money.

Perhaps we might one day see patients demanding the use of such medical devices in the same way cancer patients have demonstrated over the refusal to give them new therapies.

Preventive medicine for breast cancer

Fergus Walsh | 18:24 UK time, Monday, 28 March 2011


The idea of drug treatment to prevent cardiovascular disease is well-established. Not so with cancer. Now a panel of cancer experts, writing in Lancet Oncology have suggested that drugs such as tamoxifen could reduce the chances of developing breast cancer. You can read more about the story here.

Tamoxifen is a powerful medicine and the researchers make clear that it is not without side-effects. So women would need to think carefully before deciding whether they wanted to take the treatment long-term.

As with all medicines it comes down to an assessment of risks versus benefits, but that is especially important when healthy individuals take a treatment.

Professor Jack Cuzick, an epidemiologist at Queen Mary, University of London put the risk-benefit analysis this way: "For every 1,000 women on tamoxifen for 10 years, we estimate there would be 20 fewer breast cancers. But there would be three more womb cancers and six more deep vein thromboses."

So a key factor will be identifying women who are at increased risk of breast cancer. Among measures already taken into account are family history and increasing age. The researchers say increased breast density - visible on mammograms - could also be a useful assessment tool.

There are other factors which affect a woman's lifetime risk such as reproductive history and issues such as bodyweight, physical activity and alcohol intake. The Cancer Research UK website has a huge amount of information.

Tamoxifen is not licensed as a preventive therapy, and is off-patent. Professor Cuzick suggested this meant there was no great financial motive for the pharmaceutical industry to push for it to be licensed for prevention. He hopes current trials might eventually persuade NICE, the health watchdog, to back it as a preventive treatment.

Japan nuclear leak and tap water

Fergus Walsh | 17:48 UK time, Wednesday, 23 March 2011


News from Tokyo that radiation in the water supply is twice the level considered safe for infants is yet another worry for the citizens of Japan. The authorities there have recommended that people in the city do not allow babies under one to drink tap water. So how much risk is there?

As many people have pointed out, and has been mentioned here before, we are all exposed to radiation all the time, from the environment and from medical procedures like x-rays. The Health Protection Agency says the average dose per year in the UK is around 2.7 millisieverts (mSv), but is higher for people in some parts of the country. In Cornwall, the average annual radioactive radon dose to people is 7.8 mSv.

So what about Japan? There were reports that Tokyo's tap water contained, at one point, 210 becquerels of radioactive iodine per litre. That is twice the recommended limit of 100 becquerels for infants although below the 300 limit for adults. Becquerels is a measure of radiation emmitted whereas millisieverts is a measure of dosage on the body (there are many handy guides to these terms on the web).

Professor Richard Wakeford from the Dalton Nuclear Institute and visiting Professor of Epidemiology at Manchester University said the health effects would be extremely small. He calculated that drinking water for a year at the Japanese limit would give an infant a dose of 0.4mSv, so you would need to double that to get the effect of drinking water at the higher level of radiation for a year. Professor Wakeford said "in theory, there would be a very small additional risk of cancer, but in practice nothing more than you could expect to get from normal background levels of radiation".

So the extra risk from drinking tap water in Tokyo for a year would be far less than that of someone moving, say, from London to Cornwall for a year.

As several scientists have pointed out, the alert about drinking water in Tokyo is simply a sensible precautionary measure, based on the principle that if you can easily avoid risk, you should do so.

Dr Jim Smith, Reader in Environmental Physics at the University of Portsmouth said: "It should be emphasised that the limit is set at a low level to ensure that consumption at that level is safe over a fairly long period of time. This means that consumption of small amounts of tap water - a few litres, say - at twice the recommended limit would not present a significant health risk. I would expect that the recommendation not to drink tap water would also extend to women who are pregnant or breastfeeding."

Prof Wakeford added: "The primary objective is to limit the radiation dose to the thyroid gland of infants and young children, because it is well established that infants and young children are at the greatest risk from the accumulation of radioactive iodine in the thyroid. The contamination limits keep the resultant doses to tolerable levels."

Nonetheless, one bit of newswire copy said that the tap water alert in Tokyo was sending "anxiety levels soaring over the nation's food and water supply". Residents in Tokyo are reportedly clearing the supermarket shelves of tap water. On Sunday, milk, spinach and other vegetables from areas near the Fukushima plant were found to have radiation levels higher than regulated standards, but the Japanese authorities said it did not pose an immediate risk to health.

I do not mean to underplay the issue of the Fukushima nuclear leak. But the dangers from Tokyo tapwater do not bear any comparison with the earthquake and tsunami where there are currently nearly 9,500 confirmed dead and more than 14,700 people still missing.

Japan nuclear leak - health risks 3

Fergus Walsh | 14:38 UK time, Thursday, 17 March 2011


"The situation is definitely more serious". That is how the government's Chief Scientist has summed up the rapidly developing crisis at Fukushima. Professor John Beddington altered his assessment of the situation because of the loss of water covering spent fuel rods stored in ponds close to the reactors.

In this rapidly developing crisis, this is causing "considerable concern" according to Professor Beddington, speaking in a TV interview. American, French and British nuclear experts who are monitoring the situation believe that the pond in Reactor 4 is all but gone.

He explained that the worst case scenario is that the fuel rods could start to burn and emit substantial amounts of nuclear material into the atmosphere. Professor Beddington said he was also "extremely worried" that the fuel tanks in Reactors 5 and 6 are leaking and if open to the air might emit significant amounts of radiation which would undermine the ability of the Japanese emergency workers to continue their efforts to control the situation.

So what does this mean for the potential health risks? Up to now Professor Beddington had supported the line taken by the Japanese authorities, that any danger was confined to within a 30 kilometre (18 mile) radius of the reactors.

Now he believes: "The situation is definitely more serious both within the area and further afield". The Scientific Advice Group for Emergencies (SAGE) which advises the government, have looked at "plausible worst case scenarios". For days that has been a potential meltdown of some of the reactor nuclear material but now a potential fire and release of radioactive material from the fuel rods has to be added in. Professor Beddington said if both these things happened and there were unfavourable winds, then radioactive material could affect Tokyo.

But he added this caveat: "Even in that situation we think the level of radiation that would come into the Tokyo area would be such that you could mitigate against it with relatively straightforward and simple measures - such as staying indoors with the windows closed."

British nationals are being advised to stay at least 80 kilometres (50 miles) from the nuclear plant, and to consider leaving Tokyo.

update 1530

"We are right to be worried by need to put the risks in context" said Gerry Thomas, Professor of Medical Pathology at Imperial College London. She is concerned that the dangers to human health are being exaggerated by some in the international media and could cause "psychological damage" to the Japanese.

She said that, even in the worst-case scenario, with a large release of radioactive material from Fukushima, the health dangers would be minimal.

"The Japanese are doing the right things - giving people iodine tablets, setting up an exclusion zone and asking people to stay indoors". Even if radiation from Fukushima reached Tokyo she believes the long-term health risks would be minimal.

Gerry Thomas is an expert in the health effects of radiation and has been studying tissue samples from many of the cancer patients affected by the Chernobyl disaster. Like other experts she said Fukushima was in no way as serious as Chernobyl and she urged those reporting the situation not to overplay the situation.

Japan nuclear leak - health risks 2

Fergus Walsh | 12:36 UK time, Thursday, 17 March 2011


Images of helicopters dropping sea-water on the Fukushima nuclear power station, and of some worried residents leaving Tokyo, present a startling and unsettling picture. Watching the news and reading the papers it would be easy to be left with the impression that the health risks from the nuclear leak are rapidly escalating and spreading far beyond the exclusion zone.

The latest advice from the British Foreign Office may also add to the sense of unease:

"Due to the evolving situation at the Fukushima nuclear facility and potential disruptions to the supply of goods, transport, communications, power and other infrastructure, British nationals currently in Tokyo and to the north of Tokyo should consider leaving the area."

But if you read on, the travel advisory from the FCO is more reassuring:

"The most recent advice from the UK's Chief Scientific Adviser (Sir John Beddington) remains that for those outside the exclusion zone set up by the Japanese authorities there is no real human health issue that people should be concerned about. This advice is kept under constant review."

The exclusion zone is 20 kilometres (12 miles) around the plant. Those living between 20-30 kilometres away (12-18 miles) are being advised to stay indoors.

Sir John Beddington spoke by phone two days ago to British Embassy staff in Tokyo and a transcription of his comments is, I think, worth setting out in detail. He said:

" we have any concerns now in terms of human health? Well the answer is yes we do, but only in the immediate vicinity of the reactors. So the 20 kilometre exclusion zone the Japanese have actually imposed is sensible and proportionate. If they extended out a little bit more to 30 kms, that is well within the sort of parameters that we would think are extremely safe."

Of course, everyone is concerned about what might happen if the situation at Fukushima gets worse. Sir John went on to talk about the worse case scenario - a meltdown at the plant. He did not think this was likely, but what would be the result if it did?

"In this reasonable worst case you get an explosion. You get some radioactive material going up to about 500m up into the air. Now, that's really serious, but it's serious again for the local area....The problems are within 30 km of the reactor. And to give you a flavour for that, when Chernobyl had a massive fire at the graphite core, material was going up not just 500m but to 30,000 feet (9,144m) . It was lasting not for the odd hour or so but lasted months, and that was putting nuclear radioactive material up into the upper atmosphere for a very long period of time. But even in the case of Chernobyl, the exclusion zone that they had was about 30km. And in that exclusion zone, outside that, there is no evidence whatsoever to indicate people had problems from the radiation. The problems with Chernobyl were people were continuing to drink the water, continuing to eat vegetables and so on and that was where the problems came from. That's not going to be the case here. So what I would really re-emphasise is that this is very problematic for the area and the immediate vicinity and one has to have concerns for the people working there. Beyond that 20-30km, it's really not an issue for health".

Sir John is not alone in his assessment of the health risks. It is similar to comments I have heard by many other scientists.

On Today on BBC Radio 4, Professor Laurence Williams, former UK chief inspector of nuclear installations, stressed that Fukushima was not another Chernobyl and made it clear if he was living in Tokyo he would not leave:

"....I wouldn't be concerned. This is not a Chernobyl. We are not going to see high levels of radioactivity being put up high into the atmosphere and distributed on the winds. If we do get to the worse situation where the fuel in those reactors slumps because it doesn't have any structural integrity because of over-heating, then there will be a release of caesium and iodine (although the iodine is decaying all the time) and there will be strontium and ruthenium and other things that will come guess is it is a low-level release and very localised it will not be like Chernobyl. People living in Tokyo are 150 miles (241km) away, so I would not be worried."

So even in the worst-case scenario, the risks to human health beyond the exclusion zone appear to be low. The main immediate threat to health is to the emergency workers trying to stabilise the plant. Radiation levels at the plant have fluctuated and we don't know exactly what materials are leaking out, nor in what quantity, nor over what time period.

Finally a note on potassium iodide tablets. Radioactive iodine from a nuclear leak can pollute the air and contaminate the food chain. Potassium iodide tablets can block radioactive iodine from being taken into the thyroid. The Japanese authorities have distributed these to people in the vicinity of Fukushima as a precautionary measure. But sales of iodide tablets have also soared in the US, thousands of miles away. It is not proportionate or sensible, but an indication of the level of unease that a nuclear accident can cause.

Japan nuclear leak - health risks

Fergus Walsh | 19:57 UK time, Tuesday, 15 March 2011


It is not surprising that many people in Japan are deeply worried about the potential health threat from the radiation leak at the Fukushima nuclear plant. The earthquake and subsequent tsunami produced tangible, visible destruction whereas radiation is an invisible danger.

The images of families being screened for contamination by workers in protective suits add to the sense of alarm. So what are the risks at present? Scientists I have spoken to say we cannot give a clear answer yet because we don't know enough about the amount and type of radioactive material that has leaked. Nonetheless, most experts seem to suggest the danger to the public is low.

To start with, some background on radiation exposure which is measured in the unit known as sievert. This quantifies the amount of radiation absorbed by human tissues.

It is worth pointing out that everyone gets exposed to radiation, all the time. This is from the air, cosmic rays, food, water and so on. The levels are very low.

Figures from the Health Protection Agency say:

A chest x-ray gives a dose of about 20 microsieverts (that is 20 millionths of a sievert)

The average annual background radiation dose for individuals in the UK is 2,200 microsieverts.

So how does that compare with what is happening in Japan? Earlier today, a Japanese minister said at one point, anyone at the Fukushima plant itself would be exposed to 11,000 microsieverts per hour, but this had fallen back.

At another point radiation levels are said to have reached as high as 400 millisieverts (one millisievert is 1,000 microsieverts). That would be 20 times the annual permitted limit for nuclear workers. Clearly it is the small group of nuclear workers remaining at the plant who are most at risk.

For the public there is a 20 kilometre (12 mile) exclusion zone around the plant. People living up to 30 kilometres (18 miles) away have been told to stay indoors. "That would be effective in reducing the chances of inhaling radiation from an airborne plume" said Steve Jones, Professor of Environmental and Occupational Toxicology at the University of Central Lancashire. He said, "We don't know what is in that plume released after explosions at the plant, but the risk would decrease very quickly the further away you travel from the site."

All of the experts I spoke to said the health risks to the public, at present, were low. Professor Jones said if the situation did not get worse then it would probably be impossible to show any measurable health effects on the wider public in the decades to come. Cancer is a key long-term risk from radiation exposure and officials will undoubtedly be monitoring the health outcomes of the population around Fukushima..

So how does the danger compare to the worst nuclear accident in history, at Chernobyl, 25 years ago? The radiation leak in Japan is minute by comparison. At Chernobyl a huge explosion was followed by a fire which raged for 10 days and emitted a huge amount of radiation which spread over a vast area.

In a report on the 20th anniversary of the disaster, the World Health Organisation said up to 4000 people may eventually die from the health effects of radiation poisoning, but so far there had been around 60 deaths. Around 50 of those were emergency workers and nine children who died from thyroid cancer. Children are especially at risk from radiation poisoning because of their developing bodies.

Dr Jim Smith, Reader in Environmental Physics at Portsmouth University and author of "Chernobyl: Catastrophe and Consequences" spoke to me from Kiev. He is part of a team on its his way to visit Chernobyl.

He said: "The Chernobyl disaster resulted in a major release of radioactivity. It was a graphite reactor and huge amounts of radioactive caesium and iodine escaped. It was partly due to the design of the plant - very different from those in Japan."

He said several hundred thousand people worked on the subsequent clean up and decontamination of the plant. Many had received an average of around 100 millisieverts over the duration of their work at the site. Professor Smith estimated that this had increased their lifetime risk of cancer to the extent that for every 100 workers an extra one would get cancer. This is not a risk anyone would choose to take, but he pointed out it was far less than the danger of cancer from being a life-long smoker.

One of the main health effects of the Japanese radiation leak maybe the psychological impact. Professor Jones said the stress of being displaced from your home and the fear of radiation contamination could have serious consequences. And that fear factor extends as far as Tokyo, 155 miles from the nuclear plant. "Even though people in Tokyo maybe completely safe, it is understandable that they are nervous and that can lead to stress and ill-health", he said.

Can smoking be stubbed out?

Fergus Walsh | 20:32 UK time, Wednesday, 9 March 2011

Comments (52)

Cigarettes on display in a shop

I have just spent the day in Blackpool which has the highest rate of adult smoking in England. Here, 35% of adults smoke, compared with 21% across England as a whole.

If smoking is to be stubbed out then something drastic needs to happen in this seaside town.

I was also staggered by the news that one in three pregnant women in Blackpool smoke - twice the national rate.

We met two mums who smoked while pregnant. One said she was devastated when told her daughter's low birth weight was down to her smoking. But she has still not kicked the habit.

Most smokers here told me they started aged 13 or 14 - one man said he was 10.

Why is smoking so prevalent here? It is a deprived area with high unemployment.

And put simply, poorer communities smoke more than affluent ones.

"A Smokefree Future", published in 2010, said that until the mid-1950s, socio-economic groups smoked at similarly high rates. Since then, as evidence has emerged of the harm it causes, a wide gap has emerged, and tobacco use is now said to be the primary reason for the gap in healthy life expectancy between rich and poor.

People from disadvantaged groups are less likely to give up than the more affluent or educated. Children often follow the patterns of behaviour set down by their parents and peer groups. It is this cycle of smoking and ill-health that tobacco control strategies need to address.

And Blackpool says it is trying to fight back. Its "Altogether Now" strategy is aimed at encouraging residents to improve their health. The premiership football ground is completely non-smoking and the players are health champions.

Any smoking reduction strategy has to be geared towards the young - around 200,000 young people take up smoking in England each year.

In that vein, the ban on tobacco displays was welcomed by NHS Blackpool.

Jane Roberts, head of tobacco control, said: "Cigarettes are not like Mars bars - children should not see them when they walk into a shop."

She said removing displays would also help prevent impulse purchases by smokers.

But smokers were more dubious about the suggestion that tobacco should be sold in plain packaging.

One worker in a hard hat summed up the mood: "It would not stop me from smoking. I do it because I like it. Plain packaging won't make any difference."

But some did think that removing the brightly coloured logos and trademarks might deter the young.

The government says it has an open mind on plain packaging, but the idea has now gone out for lengthy consultation.

The tobacco industry would fiercely oppose any further restrictions on the sale of what is, after all, a legal product.

Some argue that the measures are another sign of the nanny state in action.

Britain has come a long way since the heyday of tobacco in the late 1940s when eight out of 10 men smoked.

When I first worked at Broadcasting House in London the newsroom had a constant fug of cigarette smoke. I remember one brilliant writer who used to light up a cigar each afternoon as he prepared to dictate the headlines to a typist.

Smoking on the Underground, in planes and in coaches was permitted and tobacco advertising was everywhere. Now you can't light up in a pub or workplace, and a ban on sales of cigarettes from vending machines is due to come in later this year, subject to a legal challenge.

A lot has changed - but 100,000 people in Britain still die from smoking-related causes each year.

The statistics are sobering. One in two life-long smokers will be killed by their habit. Sadly, my mother was one of them.

De-normalising smoking is a key part of discouraging the young from taking up the habit.

And if smoking rates do come down further it will have a dramatic benefit on the health of the nation.

Lab-grown brain cells should aid research into Alzheimer's

Fergus Walsh | 14:12 UK time, Friday, 4 March 2011


Scientists in the United States have managed to turn human embryonic stem cells into a type of brain cell linked to memory loss in Alzheimer's disease. The research, published in the journal Stem Cells, should help in the development and testing of potential new medicines to treat the neurodegenerative disease which affects around half a million people in the UK.

The researchers at Northwestern University in Chicago managed to coax the stem cells into becoming a type of neuron which dies off early in people with Alzheimer's disease. The cells in question are basal forebrain cholinergic neurons (BFCN), which have a key role in memory function, and their loss is thought to be significant in the early stages of the neurodegenerative condition.

These dishes of cells should provide a near limitless supply of neurons for research. Scientists need to know why these cells - critical for memory function - fail in Alzheimer's disease. It should enable them to test compounds on the laboratory samples in the search for treatments.

One of the authors of the study, John Kessler, chair of neurology at Northwestern University said: "We can literally screen tens of thousands of drugs at a time to find the kind of compound that will keep these cells alive. We can ultimately think about transplanting the cells to help the memory deficit." He said his team had also created the neurons from the skin cells of Alzheimer's patients and from healthy volunteers. He was cautious about when the research might yield treatments but said 10 years appeared "realistic".

The Alzheimer's Society said the study was a "major step forward" but went on to say that further research was needed to find out whether these stem cells actually work in the brain. It urged greater investment in dementia research. The term "major breakthrough" was used on the Today programme on BBC Radio 4 although it was made crystal clear that benefits for patients were a long way off.

Another charity, Alzheimer's Research UK was more cautious. It said the prospect of stem cells being used as a treatment for the disease was still a very long way off and there was no evidence yet to suggest this method would be able to help people with dementia.

I confess I worry about the phrases "major breakthrough" and "major step forward". For me, the former should be reserved for something which is a game-changing piece of research, or a new device or treatment which transforms the way we combat a condition. Like many things it's hard to describe, but you know it when you see it. "Major step forward" is problematic unless you also know how many steps there are left to travel on a journey.

It seems to me that this research is another tantalising example of what MIGHT ultimately be achieved through manipulating human embryonic stem cells - the body's master cells.

Being able to generate the neurons which fail in early Alzheimer's and to test agents on them that may promote survival, will be extremely useful. But families affects by Alzheimer's need to know that there are a whole lot of major steps forward still needed before it yields an effective treatment for the disease.

(Another) urine test for prostate cancer

Fergus Walsh | 16:19 UK time, Tuesday, 1 March 2011


An encouraging development in the diagnosis of prostate cancer - the most common cancer in men. Scientists at the University of Surrey have developed a urine test which - in an early trial - was at least twice as good at detecting prostate cancer than the current test.

Last October, Cancer Research UK scientists in Cambridge also announced early results of a prototype urine test. The CRUK researchers looked at levels of a protein found in urine called MSMB, and in a small study were able to diagnose prostate cancer from urine samples with about 50% accuracy.

The team at the University of Surrey focussed on another protein, Engrailed-2 (EN2) which is made by prostate cancers and secreted into urine. In a study of nearly 300 men published in the US journal Clinical Cancer Research, they found the test was able to detect prostate cancer with 66% accuracy, and with few so-called "false positives" - where cancer was supposedly detected when the patient was free of the disease. The research was funded by the University of Surrey and The Prostate Project charity.

The standard blood test checks prostate-specific antigen (PSA) levels. Among many problems with the blood test are that PSA levels can vary widely between men and at different time. Furthermore, a raised level may indicate other prostate conditions which are not cancerous.

False positives are a significant problem with the PSA test. A raised level may prompt a significant period of anxiety for patients and mean that they undergo a needle biopsy. Here the problem can be false negatives - so a cancer may be missed if the needle does not sample the right area.

Professor Malcolm Mason from CRUK said: "There is a desperate need for a better prostate cancer test than PSA, and this latest candidate, EN2, is very welcome. However, more work needs to be done to find out whether or not EN2 is capable of distinguishing between aggressive prostate cancers that need treatment, and non-aggressive ones that don't. Almost certainly, this new marker would be used as part of a combination of several markers, including PSA.

Both the Surrey and Cambridge urine tests are promising. Indeed there are frequent research papers showing the potential of biomarkers in blood and urine for detecting cancer and other diseases. But most still have a long way to go. A blog in the Guardian last year discussed the problems involved with using these "biological fingerprints" for detecting disease.

Men hoping to benefit from the Surrey research may have to wait some time at the prostate cancer urine test is still experimental. Dr Richard Morgan, senior lecturer in Molecular Oncology at the University of Surrey said: "We are preparing several large studies in the UK and in the US and although the EN2 test is not yet available several companies have expressed interest in taking it forward."

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.